Synonyms: Zemplar®
paricalcitol is an approved drug (FDA (1998))
Compound class:
Metabolite
Comment: Vitamin D receptor agonist
|
|
Classification | |
Compound class | Metabolite |
Approved drug? | Yes (FDA (1998)) |
IUPAC Name |
(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol |
International Nonproprietary Names | |
INN number | INN |
7688 | paricalcitol |
Synonyms |
Zemplar® |
Database Links | |
CAS Registry No. | 131918-61-1 (source: Scifinder) |
ChEMBL Ligand | CHEMBL1200622 |
DrugBank Ligand | DB00910 |
DrugCentral Ligand | 2066 |
GtoPdb PubChem SID | 135651536 |
LIPID MAPS | LMST04030163 |
PubChem CID | 5281104 |
Search Google for chemical match using the InChIKey | BPKAHTKRCLCHEA-UBFJEZKGSA-N |
Search Google for chemicals with the same backbone | BPKAHTKRCLCHEA |
Search PubMed clinical trials | paricalcitol |
Search PubMed titles | paricalcitol |
Search PubMed titles/abstracts | paricalcitol |
UniChem Compound Search for chemical match using the InChIKey | BPKAHTKRCLCHEA-UBFJEZKGSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | BPKAHTKRCLCHEA-UBFJEZKGSA-N |
Wikipedia | Paricalcitol |